Litigation Details for APTALIS PHARMA US, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2017)
✉ Email this page to a colleague
APTALIS PHARMA US, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-01-30 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-08-10 |
| Cause | 15:1126 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | None | Referred To | Mark Falk |
| Patents | 8,217,083; 8,436,051 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in APTALIS PHARMA US, INC. v. ZYDUS PHARMACEUTICALS (USA), INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for APTALIS PHARMA US, INC. v. ZYDUS PHARMACEUTICALS (USA), INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-01-29 | 1 | of U.S. Patent No. 7,541,384 (“the ‘384 patent”), U.S. Patent No. 8,217,083 (“the ‘083 patent”), and …States Patent and Trademark Office (“USPTO”) on June 2, 2009. 14. U.S. Patent No. 8,217,083 (“the…Court. Count III: Infringement Of U.S. Patent No. 8,217,083 39. Aptalis repeats and incorporates…Declaratory Judgment Of Infringement Of U.S. Patent No. 8,217,083 49. Aptalis repeats and incorporates…Action This is an action for patent infringement under the patent laws of the United States, Title | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
